RISK OF BRONCHOASPIRATION IN THE PERIOPERATIVE PERIOD IN PATIENTS USING GLP-1 RECEPTOR ANALOGS: AN INTEGRATIVE LITERATURE REVIEW
DOI:
https://doi.org/10.51891/rease.v12i11.32405Keywords:
Bronchoaspiration, GLP-1 receptor Analogs, Perioperative PeriodAbstract
This article sought to analyze the association between the use of GLP-1 receptor agonists and the risk of perioperative pulmonary aspiration. This is an integrative literature review conducted across PubMed and Virtual Health Library (VHL) databases covering 2021 to 2026, using specific descriptors in English, resulting in the final selection of 49 articles. The results demonstrated that these medications inhibit phase 3 of the Migrating Motor Complex during fasting, promoting delayed gastric emptying. Although elevated residual gastric content affects 19% to 56% of users, the rate of actual clinical pulmonary aspiration remains extremely rare, below 0.3%. Among the analyzed studies, 5 indicated a higher aspiration risk, 20 showed risks equal to controls, and 24 were inconclusive. It is concluded that isolated gastric retention does not lead to a directly proportional increase in clinical aspiration when airway protective barriers are maintained. Perioperative decision-making should abandon rigid universal medication suspension rules and adopt active screening of gastrointestinal symptoms combined with bedside point-of-care gastric ultrasound (POCUS).
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY